The mRNA expression of the α1A-AR specifically was significantly decreased in the layers of the PFC in patients with AD with no changes in the α2-AR (Szot et al., 2007) and there is an α1A-AR polymorphism associated with AD (Hong et al., 2001). Here, ADORA2A is linked to Alzheimer disease.